Role of 18F-Choline PET/CT in restaging patients with prostate cancer with trigger PSA < 1 ng/ml

被引：0
|
作者：
Marzola, M. C. [1 ]
Chondrogiannis, S. [1 ]
Ferretti, A. [2 ]
Maffione, A. M. [1 ]
Rampin, L. [1 ]
Massaro, A. [1 ]
Grassetto, G. [1 ]
Rubello, D. [1 ]
机构：
[1] Santa Maria della Misericordia Hosp, Nucl Med PET CT Ctr, Rovigo, Italy
[2] Santa Maria della Misericordia Hosp, Med Phys & Biostat Unit, Rovigo, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [1] Role PSA kinetics in the detection rate of 18F-Choline PET/CT in restaging prostate cancer patients
    Chondrogiannis, S.
    Marzola, M. C.
    Rampin, L.
    Grassetto, G.
    Pavan, L.
    Maffione, A. M.
    Rubello, D.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S500 - S500
  • [2] Role of PSA kinetics in the detection rate of 18F-Choline PET/CT in restaging prostate cancer patients.
    Marzola, M. C.
    Chondrogiannis, S.
    Ferretti, A.
    Tadayyon, S.
    Rampin, L.
    Tommasi, E.
    Massaro, A.
    Rubello, D.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S460 - S461
  • [3] Oligometastatic disease (OMD) in prostate cancer (PCa) detects by 18F-Choline (FCH) PET/CT in patients with PSA levels < 5 ng/mL
    Cuppari, L.
    Guttilla, A.
    Gardi, M.
    Agostini, A.
    Cervino, A.
    Reccia, P.
    Burei, M.
    Saladini, G.
    Hodolic, M.
    Evangelista, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S701 - S702
  • [4] Therapy impact of 18F-PSMA PET/CT in biochemical recurrence of prostate cancer patients with PSA< 1 ng/ml postprostatectomy and 18F-Choline PET/CT negative
    Cozar Santiago, M.
    Garcia Garzon, J.
    Pastor Peiro, J.
    Bassa Massanas, P.
    Canoves Llombart, A.
    Aguilar Barrios, J.
    Sanz Llorens, R.
    Faus Rodrigo, V.
    Soler Lopez, M.
    Ferrer Rebolleda, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S266 - S266
  • [5] Importance of Gleason score on 18F-choline PET/CT findings in patients with biochemical relapse of prostate cancer disease (PSA&lt;1.0 ng/ml)
    Hodolic, Marina
    Cimitan, Marino
    Fettich, Jure
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [6] Value of 18F-Choline PET/CT in restaging of prostate cancer patients with biochemical recurrence
    Beheshti, M.
    Wolf, I.
    Steinmayer, M.
    Broinger, G.
    Kirchweger, B.
    Nader, M.
    Loidl, W.
    Hammer, J.
    Langsteger, W.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S270 - S270
  • [7] The Utility of 11C-Choline PET/CT in Patients Referred for Prostate Cancer Restaging With PSA &lt;5ng/ml
    Peller, P.
    McConnell, D.
    Murphy, R.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S110 - S110
  • [8] Role of 18F-Choline PET/CT in restaging patient with suspected relapse of prostate cancer.
    Pelosi, E.
    Arena, V.
    Pirro, V.
    Douroukas, A.
    Mancini, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S222 - S222
  • [9] 18F-Choline PET/MRI On The Therapeutic Approach For Prostate Cancer Patients Treated With Prostatectomy And Rising PSA Below 1 ng/ml
    Garcia, J. R.
    Blanch, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S609 - S609
  • [10] Pitfalls with 18F-Choline PET/CT in patients with prostate cancer
    Garcia Vicente, A. M.
    Nunez Garcia, A.
    Soriano Castrejon, A. M.
    Jimenez Londono, G. A.
    Cordero Garcia, J. M.
    Palomar Munoz, A.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2013, 32 (01): : 37 - 39
12345